TABLE 3.
CHARACTERISTICS | REFERENCE (N=TOTAL NUMBER OF PATIENTS) | ||||
---|---|---|---|---|---|
Sarkar et al17 (N=31) | Sarkar et al5 (N=41) | Vazquez et al16 (N=27) | Sialy et al30 (N=15) | ||
AGGRAVATING FACTORS | Sunlight | 14 (45.16%) | 20 (48.8%) | 18 (66.6%) | - |
Family history (melasma in at least one family member) | 5 (16.13%) | 16(39.0%) | 19 (70.4%) | - | |
Drug (Phenytoin) | 2 (6.45%) | 3 (7.3%) | 0 | - | |
Use of mustard oil | - | 18(43.9%) | 0 | - | |
Cosmetics (soaps, shaving creams, aftershave, perfumes) | - | - | 25 (92.6%) | - | |
Chronic illness (Post typhoid period, thyroid disorder, inflammatory bowel disease) | 5 (22.2%) | - | - | - | |
AGE | Range of age (years) | 19–43 | 19–53 | 25–72 | 20–40 |
Mean (years) | 34.5 | 33.5 | 38.8 | ||
DURATION | Duration of melasma | 2 months–4 years | 1 month–8 years | - | 2 months–1.5 years |
Mean duration of melasma (years) | 1.4 | 3.5 | 8 | - | |
CLINICAL PATTERN OF MELASMA | Centrofacial | 15 (48.39%) | 12(29.3%) | 12 (44.1%) | 12 (80%) |
Malar | 16 (51.61%) | 25 (61%) | 12 (44.1%) | 2 (13.3%) | |
Mandibular | 0 (0%) | 4 (9.7%) | 3 (11.1%) | 1 (6.7%) | |
WOOD LIGHT EXAMINATION | Epidermal | 15 (48.39%) | 28(68.3%) | 18 (66.6%) | - |
Mixed | 6 (19.35%) | 9 (22.0%) | 2 (7.4%) | - | |
Dermal | 10 (32.26%) | 4 (9.7%) | 7 (25.9%) | - | |
HISTOPATHOLOGICAL EXAMINATION | Epidermal | - | 10/20(50%) | 4/5 (80%) | - |
Mixed | - | 9/20 (45%) | 1/5 (20%) | - | |
Dermal | - | 1/20 (5%) | 0 | - |
Acknowledged from Sarkar R, Garg S. Melasma in men. In: Melasma: A Monograph.1st ed. Sarkar R (ed). New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd; 2015:80–84